CERE - Cerevel Therapeutics Holdings - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CERE is currently covered by 11 analysts with an average price target of $46.17. This is a potential upside of $4.52 (10.85%) from yesterday's end of day stock price of $41.65.

Cerevel Therapeutics Holdings's activity chart (see below) currently has 11 price targets and 43 ratings on display. The stock rating distribution of CERE is 51.43% HOLD and 48.57% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 56.07% with an average time for these price targets to be met of 114.93 days.

Highest price target for CERE is $45, Lowest price target is $31, average price target is $46.17.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO on 16-Feb-2024.

Currently out of the existing stock ratings of CERE, 18 are a HOLD (51.43%), 17 are a BUY (48.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

45

$3.23 (7.73%)

25

3 months 6 days ago

8/10 (80%)

$2.43 (5.71%)

67

Hold

45

$3.23 (7.73%)

25

4 months 24 days ago

3/4 (75%)

$2.56 (6.03%)

136

Hold

45

$3.23 (7.73%)

5 months 14 days ago

0/1 (0%)

$3.78 (9.17%)

Hold

45

$3.23 (7.73%)

41

5 months 15 days ago

1/6 (16.67%)

$3.87 (9.41%)

126

Hold

38

$-3.77 (-9.03%)

46

5 months 15 days ago

1/3 (33.33%)

$-3.13 (-7.61%)

434

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CERE (Cerevel Therapeutics Holdings) average time for price targets to be met?

On average it took 114.93 days on average for the stock forecasts to be realized with a an average price target met ratio 56.07

Which analyst has the current highest performing score on CERE (Cerevel Therapeutics Holdings) with a proven track record?

MATTHEW HARRISON

Which analyst has the most public recommendations on CERE (Cerevel Therapeutics Holdings)?

Matthew Harrison works at MORGAN STANLEY and has 6 price targets and 4 ratings on CERE

Which analyst is the currently most bullish on CERE (Cerevel Therapeutics Holdings)?

Cory Kasimov with highest potential upside - $21.2

Which analyst is the currently most reserved on CERE (Cerevel Therapeutics Holdings)?

Madhu Kumar with lowest potential downside - -$11.77

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?